Antiplatelet Therapy for STEMI: The Case for Cangrelor - Gregg W. Stone, MD

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Antiplatelet Therapy for STEMI: The Case for Cangrelor presented by Gregg W. Stone, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Radiologists
  • Vascular Surgeons
  • Interventional Fellows

Supported by an educational grant from AstraZeneca

Session Name: Optimization of Anticoagulation for STEMI Therapy

Track: Endovascular

Learning Objectives

Update in advances in endovascular procedures

Loading Simple Education